1997
DOI: 10.1128/aac.41.4.748
|View full text |Cite
|
Sign up to set email alerts
|

Fluconazole tolerance in clinical isolates of Cryptococcus neoformans

Abstract: Eleven isolates of Cryptococcus neoformans were investigated to determine the biochemical basis of their tolerance to fluconazole. The MICs of fluconazole for three isolates with low-level resistance were 3- to 6-fold higher than those for sensitive isolates, while the MICs for four isolates with high-level resistance were 100- to 200-fold higher than those for sensitive isolates. The level of ergosterol present in the isolates varied, and those which had relatively low levels of ergosterol were resistant to a… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

1
36
0
1

Year Published

1998
1998
2017
2017

Publication Types

Select...
5
2
2

Relationship

0
9

Authors

Journals

citations
Cited by 68 publications
(38 citation statements)
references
References 24 publications
1
36
0
1
Order By: Relevance
“…In S. cerevisiae ERG5 has been reported to bind to azole drugs by a similar mechanism as ERG11 and we observed increased expression of C. neoformans ERG5 (CNAG_06644) as well. Sterol analysis of the flucanazole resistant C. albicans showed defects in ERG2 and ERG3 [51]. Homologs of S. cerevisiae ERG2 (CNAG_00854) and ERG3 (CNAG_00519) showed altered expression levels in our microarray dataset (Figure S2).…”
Section: Resultsmentioning
confidence: 84%
“…In S. cerevisiae ERG5 has been reported to bind to azole drugs by a similar mechanism as ERG11 and we observed increased expression of C. neoformans ERG5 (CNAG_06644) as well. Sterol analysis of the flucanazole resistant C. albicans showed defects in ERG2 and ERG3 [51]. Homologs of S. cerevisiae ERG2 (CNAG_00854) and ERG3 (CNAG_00519) showed altered expression levels in our microarray dataset (Figure S2).…”
Section: Resultsmentioning
confidence: 84%
“…However, FLC-treated mice infected with C. albicans show morphologically changed yeast cells that likely stem from an inability to undergo cytokinesis (11). Isolates of C. neoformans obtained from clinical samples exhibited significant variation in susceptibility to FLC, and resistant clones with chromosomal disomy have been detected in brains of mice treated with FLC (28, 29). Thus, our in vitro data suggest that during infection with C. neoformans , treatment with FLC may lead to an increase in DNA content in yeast cells through pleiotropic effects on cell division.…”
Section: Discussionmentioning
confidence: 99%
“…In these fungi, resistance is known to emerge via (1) increased production of multidrug transporters [14][16], (2) mutations in ergosterol biosynthetic pathway genes [17],[18], (3) amplification of genomic regions that contain ergosterol biosynthetic pathway genes and transcription factors that positively regulate a subsets of efflux pump genes [19],[20] and (4) activation of Hsp90 that may facilitate the cells to respond to drug stress [21],[22]. In C. neoformans , FLC resistant strains have rarely been reported and the emergence of resistance has most often been documented with clinical outcomes of AIDS patients receiving azole maintenance therapy [23][27]. The mechanism of resistance in C. neoformans during maintenance therapy is poorly understood.…”
Section: Introductionmentioning
confidence: 99%